Atlas Trials

Anaesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine With Symptomatic Irreversible Pulpitis

Clinical trial NCT04822415 · COMPLETED

Trial details

NCT number
NCT04822415
Sponsor
Cairo University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Symptomatic Irreversible Pulpitis
Start date
2014-12-01
Primary completion
2016-12-01
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.